28 Results

People

  1. Hamlin
    Hamlin
  2. Zelenetz
    Zelenetz
  3. Matasar
    Matasar
  4. Moskowitz
    Moskowitz
  5. Kumar
    Kumar
  6. Noy
    Noy
  7. Moskowitz
    Moskowitz
  8. Sauter
    Sauter
  9. Yahalom
    Yahalom
  10. Younes
    Younes

Groups

  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. Hematologic Malignancies, Division of (28)
  4. Lymphoma (28)
  5. Survivorship Research (18)
  6. Epidemiology and Biostatistics (10)
  7. Population Sciences Research Program (10)
  8. Biostatistics Service (8)
  9. Bone Marrow Transplant (8)
  10. Executive Committee, Center for Hematologic Malignancies (8)
  1. "human"
  2. "Hematologic Malignancies, Division of"
  3. "Paul Hamlin"
Formats
  1. Journal Article (27)
  2. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. Hematologic Malignancies, Division of (28)
  4. Lymphoma (28)
  5. Survivorship Research (18)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Paul Hamlin (28)
  2. Andrew Zelenetz (17)
  3. Craig Moskowitz (12)
  4. Matthew Matasar (12)
  5. Anita Kumar (11)
  6. Ariela Noy (10)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (3)
  6. 2018 (2)

More Years

Publications
  1. Blood (3)
  2. British Journal of Haematology (3)
  3. Leukemia and Lymphoma (3)
  4. Annals of Oncology (2)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Current Oncology Reports (2)

More Publications

Publishers
  1. American Society of Hematology (4)
  2. Elsevier Inc. (3)
  3. John Wiley & Sons (3)
  4. Taylor & Francis Group (3)
  5. Ferrata Storti Foundation (2)
  6. Oxford University Press (2)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma
    Journal Article

    Grieve, C.; Joseph, A.; Drullinsky, P.; Zelenetz, A. D.; Hamlin, P.; Kumar, A.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer—Preliminary data
    Journal Article

    Alexander, K.; Hamlin, P. A.; Tew, W. P.; Trevino, K.; Tin, A. L.; Shahrokni, A.; Meditz, E.; Boparai, M.; Amirnia, F.; Sun, S. W.; more...
    Journal of the American Geriatrics Society (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma
    Journal Article

    Wang, M. L.; Jurczak, W.; Jerkeman, M.; Trotman, J.; Zinzani, P. L.; Belada, D.; Boccomini, C.; Flinn, I. W.; Giri, P.; Goy, A.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Refractive shifts and changes in corneal curvature associated with antibody-drug conjugates
    Journal Article

    Canestraro, J.; Hultcrantz, M.; Modi, S.; Hamlin, P. A.; Shoushtari, A. N.; Konner, J. A.; Tew, W. P.; Iyengar, N. M.; Heinemann, M.; Abramson, D. H.; more...
    Cornea (2022)

    Fulltext@MSK | Save
  • Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma
    Journal Article

    Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Noninvasive monitoring of mantle cell lymphoma by immunoglobulin gene next-generation sequencing in a phase 2 study of sequential chemoradioimmunotherapy followed by autologous stem-cell rescue
    Journal Article

    Kumar, A.; Bantilan, K. S.; Jacob, A. P.; Park, A.; Schoninger, S. F.; Sauter, C.; Ulaner, G. A.; Casulo, C.; Faham, M.; Kong, K. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save